Soframycin, classified under HS code 30041090, is exported to several countries, including Sri Lanka, Angola, Tanzania, Seychelles, Zambia, Maldives, Malaysia, and Guinea. The Most Favored Nation (MFN) tariff rates for this HS code vary across these nations. For instance, Sri Lanka imposes an MFN tariff rate of 0% on pharmaceutical products under HS code 30041090, aligning with its policy to facilitate access to essential medicines. Similarly, Malaysia maintains a 0% MFN tariff rate for this category, reflecting its commitment to healthcare accessibility. Other countries, such as Angola and Tanzania, apply MFN tariff rates ranging from 5% to 10%, depending on their national tariff schedules.
Regarding preferential rates under Free Trade Agreements (FTAs) with India, countries like Sri Lanka benefit from the India-Sri Lanka FTA, which allows for duty-free access to a wide range of pharmaceutical products, including those under HS code 30041090. Malaysia, as a member of the ASEAN-India FTA, also enjoys reduced or zero tariffs on such products. However, nations like Angola, Tanzania, Seychelles, Zambia, Maldives, and Guinea do not have specific FTAs with India that cover pharmaceutical products, resulting in the application of standard MFN rates.
Exemptions for essential medicines are common in many countries to promote public health. For example, Sri Lanka and Malaysia have policies that exempt essential medicines from import duties, effectively reducing the tariff rate to 0% for products like Soframycin. In contrast, countries without such exemptions apply their standard MFN or preferential rates as per their respective trade agreements and national policies.
